PMDA-2022-0043-V043

Minor variation for application PMDA-2022-0043. Minor variation: New Dosage Strength for Tiotropizone — critical change

Variation Number
PMDA-2022-0043-V043
Type
Minor
Application
PMDA-2022-0043
Change
CHG-2022-0043
Status
In Progress
Fee
€3,019
Submitted
2023-04-17
Approved
—
Description

Minor variation: New Dosage Strength for Tiotropizone — critical change